Maddalena Arigoni

2.1k citations
65 papers · 1.4k indexed · h-index 24
Topics
Immunotherapy and Immune Responses (12 papers)MicroRNA in disease regulation (10 papers)Cancer-related molecular mechanisms research (10 papers)

In The Last Decade

Maddalena Arigoni

61 papers receiving 1.4k citations

Peers

Maddalena Arigoni
Comparison fields: 5 of 107
  • Molecular Biology 789
  • Cancer Research 431
  • Immunology 305
  • Oncology 267
  • Pulmonary and Respiratory Medicine 201
Replace Rui Yang with:
Rui Yang China
Tim Lammens Belgium
Arja ter Elst Netherlands
Hui Sun Leong United Kingdom
Daniel Wicklein Germany
Stefano Cairo France
Jasper Mullenders Netherlands
Eiji Sugihara Japan
Felix Bachmann Switzerland
Bayasi Guleng China
Maddalena Arigoni relative to Rui Yang China Rui Yang's profile →
Citations per field
00.5×1.5×1.9×
Rui Yang · 1×
Citations per year

Countries citing papers authored by Maddalena Arigoni

Since Specialization
Citations

This map shows the geographic impact of Maddalena Arigoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maddalena Arigoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maddalena Arigoni more than expected).

Fields of papers citing papers by Maddalena Arigoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maddalena Arigoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maddalena Arigoni. The network helps show where Maddalena Arigoni may publish in the future.

Co-authorship network of co-authors of Maddalena Arigoni

This figure shows the co-authorship network connecting the top 25 collaborators of Maddalena Arigoni. A scholar is included among the top collaborators of Maddalena Arigoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maddalena Arigoni. Maddalena Arigoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 3
5 2
6 1
7 14
8 2
9 28
10 8
11 6
12 12
13 17
14 5
15 7
16 23
17 74
18 42
19 103
20 60

About Maddalena Arigoni

Maddalena Arigoni is a scholar working on Cancer Research, Immunology and Biotechnology, having authored 65 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), MicroRNA in disease regulation (10 papers) and Cancer-related molecular mechanisms research (10 papers). The work is most often cited by research in Cancer Research (431 citations), Immunology (305 citations) and Molecular Biology (789 citations). Maddalena Arigoni has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Raffaele Calogero, Federica Cavallo, Federica Riccardo, Stefania Lanzardo, Francesca Cordero, Laura Conti, Elena Quaglino, Giuseppina Barutello, Martina Olivero and Marco Beccuti. Their work appears in journals such as Blood, Bioinformatics and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026